Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

REVEALED: 2 | Vintage Vibes

Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Tylenol maker's stock lost billions after a rumor linking the medicine to autism. Wall Street says buy the dip as one bank sees a 'major overreaction'

Canaccord Genuity went on social media to gauge the reaction. Even the MAHA crowd was mixed on this one.

Fortune

Gitlab Analysts Praise Strong Revenue But Caution On Guidance

Investor sentiment around tech stocks remains volatile as companies navigate changing market dynamics and investor expectations. Amid this backdrop, Gitlab Inc.‘s (NASDAQ:GTLB) recent financial performance and strategic adjustments highlight the challenges and opportunities facing tech firms today.

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Medtronic To Rally Around 25%? Here Are 10 Top Analyst Forecasts For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Workday Wins, But Wall Street Worries: Strong Q2 Results Can't Stop Stock Slip

Shares of Workday Inc (NASDAQ:WDAY) dipped on Friday, trading at around $219.30 — down 3.64% — at last check Friday despite a strong fiscal second-quarter report.

Benzinga

Stocks Supported by Fed Rate Cut Speculation and Strength in Chip Makers

The S&P 500 Index ($SPX ) (SPY ) today is up +0.06%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.11%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.04%. September E-mini S&P futures (ESU25 ) are up +0.04%, and September E-mini Nasdaq futures...

Barchart

AMD To Rally More Than 20%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Read news from The Economist, FT, and more,
with one subscription

Amazon Stock Hit On AWS: Analysts Brush Off Growth Concerns, 'Buyers Of AMZN On Weakness'

Amazon.com Inc. (NASDAQ:AMZN) analysts raised their price targets on the stock and questioned why shares were falling Friday after reporting better-than-expected second-quarter results.

Benzinga

Should You Buy the Post-Earnings Pop in Roblox Stock?

Roblox stock jumps on a strong second-quarter and encouraging future guidance. Canaccord analysts expect RBLX shares to extend gains further in the days ahead.

Barchart

Auto Revenue Keeps Plunging at Tesla. Should You Buy the TSLA Stock Dip or Run Far Away?

Tesla stock sinks on second straight quarter of revenue decline and downbeat management commentary. Canaccord Genuity analyst still issued a bullish note in favor of TSLA shares.

Barchart

D-Wave Quantum (QBTS) Stock Is Surging: What's Going On?

Shares of D-Wave Quantum Inc (NYSE:QBTS) are surging Wednesday afternoon. The stock's rally was ignited after investment firm Canaccord Genuity initiated coverage on the quantum computing company with a Buy rating.

Benzinga

BlackSky Technology Stock Tumbled On Tuesday: What Happened?

BlackSky Technology Inc. (NYSE:BKSY) shares fell nearly 10% on Tuesday after Canaccord Genuity cut its price target on the stock.

Benzinga

Nvidia To Rally More Than 12%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Chime Financial: First Internet-Native Juggernaut Focused On Consumer Banking, Says Bullish Analyst

While there are several large companies in the digital disruption and internet-native space, Chime Financial Inc. (NASDAQ:CHYM) has emerged as the first juggernaut focused on consumer banking, according to Canaccord Genuity.

Benzinga

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Omada Health Analysts Say 'Buy' — While It's Still Below IPO Price

Canaccord Genuity and Needham analysts initiate coverage of Omada Health Inc (NASDAQ:OMDA) with a Buy rating.

Benzinga

Tesla To Rally Around 45%? Here Are 10 Top Analyst Forecasts For Thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Barchart

Analysts: Don’t Miss the ‘Silver-Linings Playbook’ in Tesla Stock Right Now

Down 43% from all-time highs, Tesla stock remains a top investment in 2025, according to analysts from Canaccord Genuity.

Benzinga

Critical Insights From Ulta Beauty Analyst Ratings: What You Need To Know

Ratings for Ulta Beauty (NASDAQ:ULTA) were provided by 28 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.

Get all your
news in one place.

100's of premium titles.
One news app.

Benzinga

Lululemon Athletica To Rally Around 28%? Here Are 10 Top Analyst Forecasts For Friday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Benzinga

Peeling Back The Layers: Exploring Atlassian Through Analyst Insights

In the latest quarter, 21 analysts provided ratings for Atlassian (NASDAQ:TEAM), showcasing a mix of bullish and bearish perspectives.

Benzinga

The Latest Analyst Ratings For Progyny

Providing a diverse range of perspectives from bullish to bearish, 12 analysts have published ratings on Progyny (NASDAQ:PGNY) in the last three months.

Benzinga

Where Hims & Hers Health Stands With Analysts

Analysts' ratings for Hims Hers Health (NYSE:HIMS) over the last quarter vary from bullish to bearish, as provided by 10 analysts.

Benzinga

Viant Technology Stock: A Deep Dive Into Analyst Perspectives (6 Ratings)

Viant Technology (NASDAQ:DSP) has been analyzed by 6 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.

Benzinga

The Analyst Verdict: Edwards Lifesciences In The Eyes Of 17 Experts

Analysts' ratings for Edwards Lifesciences (NYSE:EW) over the last quarter vary from bullish to bearish, as provided by 17 analysts.

Benzinga

Urban Outfitters To Rally Around 47%? Here Are 10 Top Analyst Forecasts For Wednesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

1 2 3 4

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.